BIAF

bioAffinity Technologies, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-16

Figures on this page computed 2026-11-08 12:40 UTC

Last close

2.72USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-16

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-03-16

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-16
    • 10-K for 2025, filed 2026-03-16
    • 10-K for 2025, filed 2026-03-16
    • 10-Q for 2025, filed 2026-08-07
    • 10-K for 2025, filed 2026-03-16
    • 10-Q for 2025, filed 2026-08-07

    The filing itself

  • -242.0%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-16
    • 10-K for 2025, filed 2026-03-16

    The filing itself

  • -152.4%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-16
    • 10-K for 2025, filed 2026-03-16

    The filing itself

  • 0.16Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-16
    • 10-Q for 2025, filed 2026-08-07

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Where the price sits

lens 6 of 9

Its multiple of earnings

n/a

We do not hold a multiple of earnings for this company, so there is nothing to place. No range is drawn in its place.

  • Where it is nown/a
  • Its sector's middle26.9x
  • The market's middle19.9x

Its own year, in the price it trades at

2.7
Year low 2.62.7Year high 79.4
Its last close is 2.7, inside a year that ran from 2.6 to 79.4.

Market data, 2026-11-06

Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.

Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.

Every figure in this lens

  • Price against earningsn/a10-K for 2025, filed 2026-03-16

    Not held.

    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001493152-26-010143
    Reported in
    USD

    The filing itself

  • Last close2.7Market data, 2026-11-06
    Source
    market
    Taken on
    2026-11-06
    Reported in
    USD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.